SBIO
Fund Stats as of 02/15/2019
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $33.95
Last Trade Price $33.92
NAV $33.95
NAV Change $0.72
Total Net Assets $186,715,393
Total Market Value $174,090,265
Premium/Discount(%) 0.00%
Difference ($) $0.00
Volume 37,359
Shares Outstanding 5,500,000
Expenses as of 03/31/2018
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Daily Fund Holdings 71 total, as of 02/15/2019, subject to change

SecuritySymbolWeight
FibroGen Inc.FGEN5.81%
Array BioPharma Inc.ARRY5.76%
United Therapeutics Corp.UTHR4.44%
Agios Pharmaceuticals Inc.AGIO4.03%
Galapagos NVGLPG3.97%
Emergent BioSolutions Inc.EBS3.94%
Ascendis Pharma ASASND3.61%
Global Blood Therapeutics Inc.GBT3.38%
Immunomedics Inc.IMMU3.05%
Ligand Pharmaceuticals Inc.LGND3.01%
Arena Pharmaceuticals Inc.ARNA2.88%
Halozyme Therapeutics Inc.HALO2.88%
Mirati Therapeutics Inc.MRTX2.76%
Insmed Inc.INSM2.44%
Madrigal Pharmaceuticals Inc.MDGL2.43%
Enanta Pharmaceuticals Inc.ENTA2.34%
Acceleron Pharma Inc.XLRN2.30%
Atara Biotherapeutics Inc.ATRA2.16%
AnaptysBio Inc.ANAB2.14%
CRISPR Therapeutics AGCRSP1.89%
PTC Therapeutics Inc.PTCT1.75%
uniQure NVQURE1.62%
Rhythm Pharmaceuticals Inc.RYTM1.21%
Fate Therapeutics Inc.FATE1.12%
MacroGenics Inc.MGNX1.07%
Vericel Corp.VCEL0.98%
ImmunoGen Inc.IMGN0.98%
G1 Therapeutics Inc.GTHX0.91%
Apellis Pharmaceuticals Inc.APLS0.91%
Acorda Therapeutics Inc.ACOR0.79%
Cara Therapeutics Inc.CARA0.78%
UroGen Pharma Ltd.URGN0.77%
Viking Therapeutics Inc.VKTX0.75%
Akebia Therapeutics Inc.AKBA0.74%
AMAG Pharmaceuticals Inc.AMAG0.67%
Kura Oncology Inc.KURA0.66%
Flexion Therapeutics Inc.FLXN0.65%
ChemoCentryx Inc.CCXI0.64%
GlycoMimetics Inc.GLYC0.60%
Corbus Pharmaceuticals Holdings Inc.CRBP0.60%
PDL BioPharma Inc.PDLI0.57%
Progenics Pharmaceuticals Inc.PGNX0.48%
Five Prime Therapeutics Inc.FPRX0.48%
NuCana PLCNCNA0.43%
ArQule Inc.ARQL0.43%
Concert Pharmaceuticals Inc.CNCE0.41%
Voyager Therapeutics Inc.VYGR0.41%
CASI Pharmaceuticals Inc.CASI0.40%
Krystal Biotech Inc.KRYS0.39%
Achillion Pharmaceuticals Inc.ACHN0.38%
Aduro Biotech Inc.ADRO0.37%
MediciNova Inc.MNOV0.37%
Abeona Therapeutics Inc.ABEO0.37%
Albireo Pharma Inc.ALBO0.37%
Minerva Neurosciences Inc.NERV0.35%
Adamas Pharmaceuticals Inc.ADMS0.33%
Catalyst Pharmaceuticals Inc.CPRX0.33%
Kiniksa Pharmaceuticals Ltd.KNSA0.32%
AC Immune SAACIU0.31%
Savara Inc.SVRA0.28%
Synlogic Inc.SYBX0.28%
Syros Pharmaceuticals Inc.SYRS0.27%
Tocagen Inc.TOCA0.25%
Athersys Inc.ATHX0.25%
MEI Pharma Inc.MEIP0.25%
Arbutus Biopharma Corp.ABUS0.25%
Calithera Biosciences Inc.CALA0.24%
Xenon Pharmaceuticals Inc.XENE0.24%
Corium International IncCORI-CVR0.00%
State Street Institutional Treasury Plus Money Market FundTPIXX0.03%
Cash and Equivalents6.74%
Total Net Assets 100.00%
Security
FibroGen Inc.
Array BioPharma Inc.
United Therapeutics Corp.
Agios Pharmaceuticals Inc.
Galapagos NV
Emergent BioSolutions Inc.
Ascendis Pharma AS
Global Blood Therapeutics Inc.
Immunomedics Inc.
Ligand Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.
Halozyme Therapeutics Inc.
Mirati Therapeutics Inc.
Insmed Inc.
Madrigal Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Acceleron Pharma Inc.
Atara Biotherapeutics Inc.
AnaptysBio Inc.
CRISPR Therapeutics AG
PTC Therapeutics Inc.
uniQure NV
Rhythm Pharmaceuticals Inc.
Fate Therapeutics Inc.
MacroGenics Inc.
Vericel Corp.
ImmunoGen Inc.
G1 Therapeutics Inc.
Apellis Pharmaceuticals Inc.
Acorda Therapeutics Inc.
Cara Therapeutics Inc.
UroGen Pharma Ltd.
Viking Therapeutics Inc.
Akebia Therapeutics Inc.
AMAG Pharmaceuticals Inc.
Kura Oncology Inc.
Flexion Therapeutics Inc.
ChemoCentryx Inc.
GlycoMimetics Inc.
Corbus Pharmaceuticals Holdings Inc.
PDL BioPharma Inc.
Progenics Pharmaceuticals Inc.
Five Prime Therapeutics Inc.
NuCana PLC
ArQule Inc.
Concert Pharmaceuticals Inc.
Voyager Therapeutics Inc.
CASI Pharmaceuticals Inc.
Krystal Biotech Inc.
Achillion Pharmaceuticals Inc.
Aduro Biotech Inc.
MediciNova Inc.
Abeona Therapeutics Inc.
Albireo Pharma Inc.
Minerva Neurosciences Inc.
Adamas Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc.
Kiniksa Pharmaceuticals Ltd.
AC Immune SA
Savara Inc.
Synlogic Inc.
Syros Pharmaceuticals Inc.
Tocagen Inc.
Athersys Inc.
MEI Pharma Inc.
Arbutus Biopharma Corp.
Calithera Biosciences Inc.
Xenon Pharmaceuticals Inc.
Corium International Inc
State Street Institutional Treasury Plus Money Market Fund
Cash and Equivalents
Total Net Assets